Deafness - peripheral neuropathy - arterial disease (Q68638): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 16:38, 14 August 2026
Deafness - peripheral neuropathy - arterial disease syndrome is characterised by early-onset sensorineural deafness, skin rash, headache, peripheral arterial disease (leading to gangrene after a small dose of ergotamine), peripheral neuropathy, elevation of spinal fluid protein and cells, papilledema, and contracted retinal arteries.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_498071008 |
||
| English | Deafness - peripheral neuropathy - arterial disease |
Deafness - peripheral neuropathy - arterial disease syndrome is characterised by early-onset sensorineural deafness, skin rash, headache, peripheral arterial disease (leading to gangrene after a small dose of ergotamine), peripheral neuropathy, elevation of spinal fluid protein and cells, papilledema, and contracted retinal arteries. |
Statements
CID11:ID_498071008
0 references
dki-india-ID_498071008
0 references
Concluído
0 references
13 August 2026
0 references
